MedTrace Logo

Robotic Exoskeletons in Acute Care Therapy

NCT07353892 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-01-30

No results posted yet for this study

Summary

The goal of this clinical trial is to establish the safety, feasibility, and preliminary findings of overground robotic exoskeleton early ambulation (ORE-EA) compared to usual care early ambulation (UC-EA) in the rehabilitation of patients who have had cardiovascular or thoracic surgery. The main questions it aims to answer are:

* Is there a difference between groups in time between surgery and ambulation?
* Are there differences in safety and feasibility?

Conditions

  • Patients Post-cardiothoracic Surgery

Interventions

DEVICE

Overground robotic exoskeleton early ambulation (ORE-EA)

Overground robotic exoskeleton early ambulation (ORE-EA)

OTHER

Usual care early ambulation (UC-EA)

Usual care early ambulation (UC-EA) program for rehabilitation

Sponsors & Collaborators

  • Baylor Research Institute

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-02
Primary Completion
2027-01-01
Completion
2027-07-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07353892 on ClinicalTrials.gov